To biopsy or not to biopsy: Henoch-Schönlein nephritis in children, a 5-year follow-up study.
Henoch-Schönlein purpura
IgA vasculitis
Kidney biopsy
Nephropathy
Proteinuria
Journal
Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
received:
19
01
2021
accepted:
13
04
2021
revised:
24
03
2021
pubmed:
6
7
2021
medline:
30
3
2022
entrez:
5
7
2021
Statut:
ppublish
Résumé
The prognosis of Henoch-Schönlein purpura (HSP), IgA vasculitis, depends on kidney involvement. There is no consensus on the initiation of treatment for HSP nephritis (HSPN). Some centres start treatment before performing a kidney biopsy (KB) while in others, treatment is dictated by the importance of the clinical, biological and histological signs. The aim of this study was to evaluate which of these two approaches is associated with a better kidney outcome at 5-year follow-up. This multicentre, retrospective, nonrandomised study included children treated for HSPN between 2006 and 2010 in a French paediatric nephrology unit. One group had an early KB at diagnosis (before starting treatment or in the 15 following days). In the second group, initial treatment was decided without performing a KB. Among the 107 children included, 63.5% had an early KB at diagnosis. Follow-up at 5 years was completed in 44 children (28 KB at diagnosis, 16 no KB at diagnosis). Median urine protein/creatinine at 5 years was 2.5 mg/mmol in the early biopsy diagnosis group and 12.5 mg/mmol in the non-biopsy group. An antiproteinuric treatment was given, at 5 years, to 35.7% of the early biopsy at diagnosis children and in 62.5% of the non-biopsied children. Children with early KB at diagnosis seem to have a better renal outcome at 5 years compared to those without an early biopsy at diagnosis or biopsied later. However, this is a small patient cohort and data are missing. Further work is needed to build consensual guidelines on the management of HSPN in children.
Sections du résumé
BACKGROUND
The prognosis of Henoch-Schönlein purpura (HSP), IgA vasculitis, depends on kidney involvement. There is no consensus on the initiation of treatment for HSP nephritis (HSPN). Some centres start treatment before performing a kidney biopsy (KB) while in others, treatment is dictated by the importance of the clinical, biological and histological signs. The aim of this study was to evaluate which of these two approaches is associated with a better kidney outcome at 5-year follow-up.
METHODS
This multicentre, retrospective, nonrandomised study included children treated for HSPN between 2006 and 2010 in a French paediatric nephrology unit. One group had an early KB at diagnosis (before starting treatment or in the 15 following days). In the second group, initial treatment was decided without performing a KB.
RESULTS
Among the 107 children included, 63.5% had an early KB at diagnosis. Follow-up at 5 years was completed in 44 children (28 KB at diagnosis, 16 no KB at diagnosis). Median urine protein/creatinine at 5 years was 2.5 mg/mmol in the early biopsy diagnosis group and 12.5 mg/mmol in the non-biopsy group. An antiproteinuric treatment was given, at 5 years, to 35.7% of the early biopsy at diagnosis children and in 62.5% of the non-biopsied children.
CONCLUSIONS
Children with early KB at diagnosis seem to have a better renal outcome at 5 years compared to those without an early biopsy at diagnosis or biopsied later. However, this is a small patient cohort and data are missing. Further work is needed to build consensual guidelines on the management of HSPN in children.
Identifiants
pubmed: 34224002
doi: 10.1007/s00467-021-05086-9
pii: 10.1007/s00467-021-05086-9
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
147-152Informations de copyright
© 2021. IPNA.
Références
Davin J-C, Coppo R (2014) Henoch-Schönlein purpura nephritis in children. Nat Rev Nephrol 10:563–573
doi: 10.1038/nrneph.2014.126
Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L (2006) Predictors of outcome in Henoch-Schonlein nephritis in children and adults. Am J Kidney Dis 47:993–1003
doi: 10.1053/j.ajkd.2006.02.178
Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, Jahnukainen T, Rajanti J, Ormälä T, Turtinen J, Nuutinen M (2010) Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children. Arch Dis Child 95:877–882
doi: 10.1136/adc.2009.182394
Goldstein AR, White RH, Akuse R, Chantler C (1992) Long-term follow-up of childhood. Henoch-Schonlein nephritis. Lancet 339:280–282
doi: 10.1016/0140-6736(92)91341-5
Koskimies O, Mir S, Rapola J, Vilska J (1981) Henoch-Schonlein nephritis: long-term prognosis of unselected patients. Arch Dis Child 56:482–484
doi: 10.1136/adc.56.6.482
Ronkainen J, Nuutinen M, Koskimies O (2002) The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective cohort study. Lancet 360:666–670
doi: 10.1016/S0140-6736(02)09835-5
Tudorache E, Azema C, Hogan J, Wannous H, Decramer S, Deschenes G, Ulinski T (2015) Even mild cases of paediatric Henoch-Schonlein purpura nephritis show significant long-term proteinuria. Acta Paediatr 10:843–848
doi: 10.1111/apa.12723
Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FP (1997) Long-term prognosis of Henoch–Schönlein nephritis in adults and children. Nephrol Dial Transplant 12:2277–2283
doi: 10.1093/ndt/12.11.2277
Delbet JD, Geslain G, Auger M, Hogan J, Salomon R, Peuchmaur M, Deschênes G, Buob D, Parmentier C, Ulinski T (2020) Histological prognostic factors in children with Henoch-Schönlein purpura nephritis. Pediatr Nephrol 35:313–320
doi: 10.1007/s00467-019-04363-y
Edström Halling S, Söderberg MP, Berg UB (2010) Predictors of outcome in Henoch-Schönlein nephritis. Pediatr Nephrol 25:1101–1108
doi: 10.1007/s00467-010-1444-y
Ninchoji T, Kaito H, Nozu K, Hashimura Y, Kanda K, Kamioka I, Shima Y, Hamahira K, Nakanishi K, Tanaka R, Yoshikawa N, Iijima K, Matsuo M (2011) Treatment strategies for Henoch-Schonlein purpura nephritis by histological and clinical severity. Pediatr Nephrol 26:563–569
doi: 10.1007/s00467-010-1741-5
Narchi H (2005) Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 90:916–920
doi: 10.1136/adc.2005.074641
Davin JC, Coppo R (2013) Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch-Schonlein purpura nephritis. Pediatr Nephrol 28:1897–1903
doi: 10.1007/s00467-013-2550-4
Bogdanovic R (2009) Henoch-Schönlein purpura nephritis in children: risk factors, prevention and treatment. Acta Paediatr 98:1882–1889
doi: 10.1111/j.1651-2227.2009.01445.x
White RHR, Yoshikawa N, Feehally J (1999) Chapter 41. In: Barratt TM, Avner ED, Harmon WE (eds) Pediatric Nephrology, 4th edn. Williams & Wilkins, Philadelphia, pp 691–706